BioSpace News Archive

Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2019 financial results on August 6, 2019 and members of its senior management team will host a conference call and webcast at 7:30 a.m. ET before the U.S. financial markets open.

UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people who may be affected by severe weather and flooding across parts of Louisiana, Texas and Mississippi as a result of Tropical Storm Barry.

eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance exchange, announced today that the company plans to release second quarter 2019 financial results on July 25, 2019.

There has been a lot of discussions this week about political alignment at the Council of the Federation, but we’re pleased to see that Premiers are agreeing on one of the most important issues facing this country: the state of our health care system.

More than a year after becoming one of the first medical institutions nationally to complete a revolutionary gene replacement surgery to restore vision in patients with retinal degeneration, surgeons at The Vision Center at Children’s Hospital Los Angeles have successfully completed the procedure on an additional 13 patients.

The global selective serotonin reuptake inhibitors market is expected to post a CAGR of close to 4% during the period 2019-2023, according to the latest market research report by Technavio.

Forty Seven, Inc., a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, and Ono Pharmaceutical Co., Ltd. today announced an exclusive license agreement for the development, manufacture and commercialization of 5F9, Forty Seven’s monoclonal antibody against CD47.

PharmaCentra, LLC, Concentra Solutions, Inc. and CannabisBPO are pleased to announce the appointment of their Chief Executive Officer and Founder, Daniel Berman, to The Carter Center’s Board of Councilors.

FUJIFILM Corporation (President: Kenji Sukeno; Fujifilm) and Axcelead Drug Discovery Partners Inc. (President: Yoshinori Ikeura; Axcelead) announced a collaboration to provide customers with a human induced pluripotent stem cell (iPSC)-based integrated platform for drug discovery solutions

Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.